| 1. | LEBOVITZ H E, DOLE J E, PATWARDHNAN R, et al. Rosiglitazone monotheray is effective in patients with type 2 diabetes[J]. J Cin Endocrinol Metab,2001,86:280-288. | 
				                                                        
				                                                            
				                                                                | 2. | STEWARD M, JONES N P, KRIEDER M, et al. Combiation effects if rosiglitazone and atorvas tatin on the dyslipidemia association with type 2 diabetes[J]. Diabetologia,2001,44(suppl 1):854. | 
				                                                        
				                                                            
				                                                                | 3. | MAYERSON A B, HUNDAL R S, DU FOR S, et al. The effects of rosiglitazone on insulin sensitiwity,lipolysis,and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes[J]. Diabetes,2002,51:797-802. | 
				                                                        
				                                                            
				                                                                | 4. | NOLAN J J, JONES N P, PATWARDHAN R, et al. Rosiglitazone taken once daily provides effective glycemic control in patients with Type 2 diabetes mellitus[J]. Diabetic Medicine,2000,17:287-294. |